Annual Meeting 2024 Posters
Along with keynote talks, research presentations by VALIDATE-funded projects, and time for networking, we aim to hold a Poster Session at the Annual Meeting, so that more VALIDATE members can showcase their research.
We will be adding to the as we get closer to the Annual Meeting 2024.
Quaid-i-Azam University, Pakistan
Epidemiological Distribution of Cutaneous Leishmaniasis in Pakistan (abstract)
Academia Nacional de Medicina de Buenos Aires, Argentina
The Inhibition of HIF-1α Limits the Migration of Dendritic Cells to Lymph Nodes in BCG-Vaccinated Mice (abstract)
Catholic University of Portugal, Portugal
Antigen Prioritization for the Development of Tuberculosis Vaccines (abstract)
Global Health Research & Medical Interventions for Development (GLOHMED), Nepal
Burden of Melioidosis in Nepal: A Prospective Cross-Sectional Pilot Study in Two Provinces(abstract)
Asst Prof Jelalu Kemal Birmeka
Haramaya University College of Vet Medicine, Ethiopia
The Effect of Ensete ventricosum (false banana) Corm Extract against Nephrotoxicity in Mice Caused by Anti-tuberculosis Drugs Administration (abstract)
Stellenbosch University, South Africa
Assessment of the Pharmacological Modulation of the Acute and Chronic Immune Response to Mycobacterium tuberculosis Infection via the CaMK1δ Inhibitor CS0640 in a Diet-Induced Prediabetes Murine Model (abstract)
University of Otago, New Zealand
Evasion of BCG-mediated Immune Protection by Hypervirulent Strains of Mycobacterium tuberculosis (abstract)
University of California San Francisco (UCSF), USA
Immune Pathogenesis of TB Disease and Impact of HIV Infection on risk of TB Disease Progression (abstract)
Albert Einstein College of Medicine, United States of America (USA)
A Novel Recombinant Herpes Simplex Virus -2 based Vaccine Against Tuberculosis (abstract)
Institute of Tropical Medicine Antwerp, Belgium
The Human Immunopeptidome of Cutaneous Leishmaniasis Across the Clinical Spectrum: New Targets for Vaccine Design? (abstract)
National University of Asuncion (IICS-UNA), Paraguay
Exploring the Role of M. leprae PGL-I as a Lipid Droplet-inducing Molecule in Schwann cells. (abstract)
MRC The Gambia at LSHTM, Gambia
Investigating West Africa Circulating Mycobacterium tuberculosis Complex Lineages Response to Anti-Tuberculosis Treatment Approaches (abstract)
Stellenbosch University, South Africa
Identification and Molecular Characterization of Mycobacterium bovis DNA in GeneXpert® MTB/RIF Ultra-Positive, Culture-Negative Sputum Samples from a Rural Community in South Africa (abstract)
ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT), India
Immunosenescence and Inflammation in Cured Tuberculosis Patients: Implications for Revaccination Program (abstract)
University Mohammed VI Polytechnic (UM6P), Morocco
In Silico Screening of Potential Inhibitors of Mycobacterium tuberculosis Mycolic Acid Cell Wall Development Using Mullein weed Bioactive Compounds (abstract)
Banaras Hindu University, India
Persistence of Leishmania-specific T-cell Responses in People Cured of Visceral Leishmaniasis (abstract)
Miss Millicent Naa Koshie Lamptey
KCCR & KNUST, Ghana
BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release (abstract)
Stellenbosch University, South Africa
Anti-mycobacterial Efficacy of Curdlan-Functionalized Nanoparticles and their Influence on Macrophage Phenotype in vitro (abstract)
Bayero University, Nigeria
Influence of Single Nucleotide Polymorphism of INF-γ (rs.2430561, +874 A/T) on the Risk of Tuberculosis and Susceptibility to Treatment in Kaduna State, Nigeria (abstract)
Federal Teaching Hospital Abakaliki Ebonyi State, Nigeria
A Qualitative Study on Community Perception and Perceived Stigma of Leprosy in Ebonyi State, South-east, Nigeria (abstract)
Bahir Dar University, Ethiopia
Comparative Whole Genome Sequence Analysis of Mycobacterium tuberculosis Isolated from Pulmonary Tuberculosis and Tuberculous Lymphadenitis Cases in Northwest Ethiopia Genomic Diversity, Transmission Dynamics and In-Silico Molecular Drug Resistance (abstract)
University of Ghana, Ghana
Pseudogenomic Insights Into the Evolution of Mycobacterium ulcerans Suggests Environmental Niche Adaptation (abstract)
Karolinska Institutet, Sweden
Protein-based Biomarker Discovery in Tuberculosis (abstract)
Zambart, Zambia
"Ubumi Bwandi” (My health, my choice): Integrated wellness screening and prevention in Zambia (abstract)
Stellenbosch University, South Africa
An Ex Vivo Model for Understanding the Impact of Vaccination on Mycobacterial Persister Populations (abstract)
Pasteur Institute of Madagascar, Madagascar
RISK6 and Sweeney3 Human Blood Transcriptomic Signatures Evaluation for Tuberculosis Diagnosis and Treatment Monitoring (abstract)
UK Health Security Agency (UKHSA), United Kingdom (UK)
Histopathology and Cellular Profiles of Experimental TB Granulomas in Guinea Pigs (abstract)
TB Vaccine Ddevelopment: Considerations for Production in Low-and middle-income Countries (abstract)
Central University of Rajasthan (CURAJ), India
Mycobacterium tuberculosis Protein Tyrosine Phosphatase B as Vaccine Candidate against Tuberculosis (abstract)
ENCB - Escuela Nacional de Ciencias Biológicas Unidad Santo Tomás IPN, Mexico
Developing Nanoparticle-Based Vaccines Against Burkholderia pseudomallei (abstract)
MRC The Gambia at LSHTM, Gambia
Macrophages Differentiation and Mycobacterium tuberculosis Complex Lineages Influence the Response to Tyrosine Kinase Inhibitor Erlotinib (abstract)
UK Health Security Agency (UKHSA), United Kingdom (UK)
Identifying Immune Signatures Associated with Inherent Resistance to Mycobacterium tuberculosis (abstract)
Bahir Dar University, Ethiopia
Clinical Presentations, Parasite Genotypes, Gene Expression and Immunological Profiles of Cutaneous Leishmaniasis Patients in Lay Gayint, Northwest Ethiopia (abstract)
